You’d be hard-pressed to find any character on the General Hospital canvas who riles up fans more than Drew (Cameron Mathison ...

Nick Cantrell has played the lead character of Jean Valjean over 1,400 times. How does he see the story and its characters?

Australia’s leading independent law firm, Corrs Chambers Westgarth, has advised Cosette Pharmaceuticals, Inc (Cosette) on its pending A$672 million acquisition of Mayne Pharma Group Limited (Mayne) ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to ...

Bridgewater-based Cosette Pharmaceuticals announced Feb. 20 it entered into an agreement to acquire Mayne Pharma Group Ltd. in a $430 million deal. Mayne is an Australian-headquartered specialty ...

Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of ...

BRIDGEWATER, N.J., February 20, 2025--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it ...

Rise Again and Key To The Mint pleased when the horses were exercised here on Wednesday morning (March 13). Outer sand: 600m: Multiwave (Jitendra Singh) 42. In fine trim. Crown Drive (S. Kabdhar) 40.5 ...

With a $430 million buyout of Australia’s Mayne Pharma locked down, Cosette Pharmaceuticals is looking to become a leading force in women’s healthcare. The New Jersey-based drugmaker agreed to ...

Students from Lake Shore High School and Kennedy Middle School helped St. Clair Shores firefighters stuff pastic eggs for ...

Cosette Pharmaceuticals Inc. announced plans to acquire Adelaide, Australia-based Mayne Pharma Pty Ltd. for AU$672 million (US$430 million) to grow its women’s health and dermatology franchise in the ...

Cosette Pharmaceuticals Inc, which is backed by Avista Healthcare Partners and Hamilton Lane, has agreed to acquire Mayne Pharma, an Australian specialty pharmaceutical company, for $430 million.